Literature DB >> 4987693

The absorption, distribution, excretion, and biotransformation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in animals.

V T Oliverio, W M Vietzke, M K Williams, R H Adamson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4987693

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  11 in total

Review 1.  Mass balance studies, with a focus on anticancer drugs.

Authors:  Jan H Beumer; Jos H Beijnen; Jan H M Schellens
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Distribution of Bratton-Marshall-positive material in mice following intravenous injections of nitrosoureas.

Authors:  P Kari; W R McConnell; J M Finkel; D L Hill
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  The comparative disposition of [14C]-fotemustine in non-tumourous and tumourous mice.

Authors:  R M Ings; M Breen; K Devereux; A J Gray; F E Edwards; C Lucas; M Briggs; B V Robinson; D B Campbell
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

4.  Clinical pharmacokinetics of oral CCNU (lomustine).

Authors:  F Y Lee; P Workman; J T Roberts; N M Bleehen
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  The nucleotide-permeable Escherichia coli cell, a sensitive DNA repair indicator for carcinogens, mutagens, and antitumor agents binding covalently to DNA.

Authors:  H W Thielmann; H Gersbach
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-09-28

6.  Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas.

Authors:  J Brajtburg; S Elberg; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

7.  The hepatotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats. Ultrastructural evidence of a delayed microtubular toxicity.

Authors:  T Ducastelle; G Raguenez-Viotte; H Fouin-Fortunet; M Matysiak; J Hemet; J P Fillastre
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

8.  [Effect of BCNU on glutathione metabolism in human blood cells].

Authors:  H C Benöhr; H D Waller
Journal:  Klin Wochenschr       Date:  1979-08-15

9.  Some new congeners of the anticancer agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Synthesis of bifunctional analogs and water soluble derivatives and preliminary evaluation of their chemotherapeutic potential.

Authors:  G Eisenbrand; H H Fiebig; W J Zeller
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-08-30

Review 10.  Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.

Authors:  Hemant Sarin
Journal:  J Transl Med       Date:  2009-09-01       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.